- Investing Ideas
- Belgian Pharmaceuticals & Biotech Price disconnect
Belgian Pharmaceuticals & Biotech Price disconnect
Results
2
0 new
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
2 companies
argenx
Market Cap: €49.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€813.00
7D
7.6%
1Y
66.5%
UCB
Market Cap: €47.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€251.70
7D
0.7%
1Y
52.2%